These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32368310)

  • 21. Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.
    Xue S; Guo H; Wei S; Song Y; Huang J; Deng S; Li Q; Li W
    Transl Androl Urol; 2022 Sep; 11(9):1304-1317. PubMed ID: 36217399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients.
    Shen C; Chen Z; Jiang J; Zhang Y; Xu W; Peng R; Zuo W; Jiang Q; Fan Y; Fang X; Zheng B
    Front Genet; 2022; 13():1034567. PubMed ID: 36246657
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
    Zhong W; Zhang F; Huang C; Lin Y; Huang J
    Front Oncol; 2020; 10():591254. PubMed ID: 33324563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma.
    Zhang YP; Cheng YB; Li S; Zhao N; Zhu ZH
    Bioengineered; 2021 Dec; 12(1):555-564. PubMed ID: 33517850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity.
    Tang X; Zhang A; Feng Y; Su Y; Wang X; Jiang F; Ma J
    J Oncol; 2021; 2021():9997185. PubMed ID: 34764994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of genomic instability-associated long non-coding RNA signature: A prognostic risk model of clear cell renal cell carcinoma.
    Jiang D; Wu T; Shi N; Shan Y; Wang J; Jiang H; Wu Y; Wang M; Li J; Liu H; Chen M
    Front Oncol; 2022; 12():1019011. PubMed ID: 36387102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma.
    Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G
    Front Genet; 2022; 13():890641. PubMed ID: 35860468
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma.
    Yang FY; Wang Y; Wu JG; Song SL; Huang G; Xi WM; Tan LL; Wang J; Cao Q
    Oncol Lett; 2017 Sep; 14(3):2757-2764. PubMed ID: 28928816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
    Front Genet; 2021; 12():726369. PubMed ID: 34721523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
    Front Genet; 2022; 13():938259. PubMed ID: 35910212
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
    Zuo S; Wang L; Wen Y; Dai G
    J Cell Biochem; 2019 May; 120(5):7375-7385. PubMed ID: 30378181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of Long Non-coding RNAs and mRNAs in Plasma of Clear Cell Renal Cell Carcinoma Patients Using Microarray and Bioinformatic Analysis.
    Zhang B; Chu W; Wen F; Zhang L; Sun L; Hu B; Wang J; Su Q; Mei Y; Cao J; Zheng J; Mou X; Dong H; Lin X; Wang N; Ji H
    Front Oncol; 2020; 10():559730. PubMed ID: 33330027
    [No Abstract]   [Full Text] [Related]  

  • 36. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
    Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
    Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of a disulfidoptosis-related lncRNA index for prognostication in clear cell renal cell carcinoma.
    Guan R; Zuo Y; Du Q; Zhang A; Wu Y; Zheng J; Shi T; Wang L; Wang H; Yu N
    Heliyon; 2024 Jun; 10(12):e32294. PubMed ID: 38975147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
    Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
    J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma.
    Zhang Y; Zhou G; Shi W; Shi W; Hu M; Kong D; Long R; Chen N
    Sci Rep; 2023 Apr; 13(1):5740. PubMed ID: 37029263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
    Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.